Eli Lilly has further expanded its weight-loss initiatives with novel therapies such as orforglipron, an oral GLP-1 receptor ...
Jan 15 () - Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D;, betting on new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback